JULY Pharmaust Dual Catalysts, page-152

The difference from then is that PAA now posses a reformulated MPL pill that can be taken without causing vomiting and the runs.

Is it effective in a clinical situation? That is what WEHI has set out to find out.

And if it proves successful as a covid 19 treatment, then it will be likely useful as a treatment for other sars-covid muitations/strains and even other viruses and viral conditions like what causes dengue fever (ie ADE). So even if it's too late to make much impact on this pandemics (which going on the difficulties they've had with developing innoculations against earlier sars-covid outbreaks, I find not likely), it might very well still be useful as a viral treatment. We'll see.